pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

1,191 catalysts · 3,603 8k filing · 2,256 grant · 1,191 approval · 1,000 device adverse event · 896 device 510k · 642 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 30 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 1 catalyst2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts2026-11-16: 0 catalysts2026-11-17: 0 catalysts2026-11-18: 0 catalysts2026-11-19: 0 catalysts2026-11-20: 0 catalysts2026-11-21: 0 catalysts2026-11-22: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
type: approval×from 2025-12-30×clear all
type
  • 8k filing3,603
  • grant2,256
  • approval1,191
  • device adverse event1,000
  • device 510k896
  • device pma642
earnings
585
  • device recall420
  • recall222
  • phase 2 completion172
  • therapy area

    no tagged catalysts yet

    Week of Dec 29, 2025

    25
    ›Dec 30, 2025approval242d agoNEREUS (TRADIPITANT) — FDA approvalVanda Pharmaceuticals Inc.

    Sponsor: VANDA PHARMS INC. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Dec 30, 2025approval242d agoCALCIUM GLUCONATE IN SODIUM CHLORIDE (CALCIUM GLUCONATE) — FDA approvalcalcium gluconate

    Sponsor: SAGENT. Form: SOLUTION. Route: INTRAVENOUS

    full page →calcium gluconate →fda approvals ↗
    ›Dec 31, 2025approval241d agoBUPRENORPHINE HYDROCHLORIDE — FDA approvalBUPRENORPHINE HYDROCHLORIDE

    Sponsor: ACTAVIS ELIZABETH. Form: TABLET. Route: SUBLINGUAL

    full page →BUPRENORPHINE HYDROCHLORIDE →fda approvals ↗
    ›Dec 31, 2025approval241d agoHYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalIGC Pharma, Inc.

    Sponsor: SANALUZ. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Dec 31, 2025approval241d agoHYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalIGC Pharma, Inc.

    Sponsor: SANALUZ. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Dec 31, 2025approval241d agoGLATIRAMER ACETATE — FDA approvalGLATIRAMER ACETATE

    Sponsor: SCINOPHARM TAIWAN. Form: INJECTABLE. Route: SUBCUTANEOUS

    full page →GLATIRAMER ACETATE →fda approvals ↗
    ›Dec 31, 2025approval241d agoDICLOFENAC SODIUM — FDA approvalDICLOFENAC SODIUM

    Sponsor: AUROBINDO PHARMA USA. Form: TABLET, DELAYED RELEASE. Route: ORAL

    full page →DICLOFENAC SODIUM →fda approvals ↗
    ›Dec 31, 2025approval241d agoOXYMORPHONE HYDROCHLORIDE — FDA approvalOXYMORPHONE HYDROCHLORIDE

    Sponsor: AUROLIFE PHARMA LLC. Form: TABLET. Route: ORAL

    full page →OXYMORPHONE HYDROCHLORIDE →fda approvals ↗
    ›Dec 31, 2025approval241d agoHYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalacetaminophen ER

    Sponsor: STRIDES PHARMA INTL. Form: TABLET. Route: ORAL

    full page →acetaminophen ER →fda approvals ↗
    ›Dec 31, 2025approval241d agoHYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalacetaminophen ER

    Sponsor: AUROLIFE PHARMA LLC. Form: TABLET. Route: ORAL

    full page →acetaminophen ER →fda approvals ↗
    ›Dec 31, 2025approval241d agoHYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalacetaminophen ER

    Sponsor: AUROLIFE PHARMA LLC. Form: TABLET. Route: ORAL

    full page →acetaminophen ER →fda approvals ↗
    ›Dec 31, 2025approval241d agoOXYCODONE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: PHARMOBEDIENT. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Dec 31, 2025approval241d agoHYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalIGC Pharma, Inc.

    Sponsor: UPSHER SMITH LABS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Dec 31, 2025approval241d agoHYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalIGC Pharma, Inc.

    Sponsor: UPSHER SMITH LABS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Dec 31, 2025approval241d agoTRAMADOL HYDROCHLORIDE — FDA approvaltramadol hydrochloride ER

    Sponsor: SPECGX LLC. Form: TABLET. Route: ORAL

    full page →tramadol hydrochloride ER →fda approvals ↗
    ›Dec 31, 2025approval241d agoSELENIOUS ACID — FDA approvalSELENIOUS ACID

    Sponsor: RK PHARMA. Form: SOLUTION. Route: INTRAVENOUS

    full page →SELENIOUS ACID →fda approvals ↗
    ›Dec 31, 2025approval241d agoPONSTEL (MEFENAMIC ACID) — FDA approvalAvion Pharmaceuticals LLC

    Sponsor: AVION PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Dec 31, 2025approval241d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

    Sponsor: AUROBINDO PHARMA. Form: TABLET, FOR SUSPENSION. Route: ORAL

    full page →LAMOTRIGINE →fda approvals ↗
    ›Dec 31, 2025approval241d agoTRAMADOL HYDROCHLORIDE — FDA approvalSenores Pharmaceuticals Inc

    Sponsor: SENORES PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Dec 31, 2025approval241d agoTRAMADOL HYDROCHLORIDE — FDA approvalSenores Pharmaceuticals Inc

    Sponsor: SENORES PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Dec 31, 2025approval241d agoATORVASTATIN CALCIUM — FDA approvalViatris Inc

    Sponsor: UMEDICA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 2, 2026approval239d agoBUPRENORPHINE HYDROCHLORIDE — FDA approvalBUPRENORPHINE HYDROCHLORIDE

    Sponsor: RUBICON RESEARCH. Form: TABLET. Route: SUBLINGUAL

    full page →BUPRENORPHINE HYDROCHLORIDE →fda approvals ↗
    ›Jan 2, 2026approval239d agoACETAMINOPHEN AND IBUPROFEN (ACETAMINOPHEN) — FDA approvalPERRIGO Co plc

    Sponsor: TARO. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 2, 2026approval239d agoEXTENDED PHENYTOIN SODIUM (PHENYTOIN SODIUM) — FDA approvalEXTENDED PHENYTOIN SODIUM

    Sponsor: MANKIND PHARMA. Form: CAPSULE. Route: ORAL

    full page →EXTENDED PHENYTOIN SODIUM →fda approvals ↗
    ›Jan 2, 2026approval239d agoHYDROCODONE BITARTRATE AND ASPIRIN (ASPIRIN) — FDA approvalPurdue Pharma LP

    Sponsor: LGM PHARMA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗

    Week of Jan 5, 2026

    25
    ›Jan 5, 2026approval236d agoLORAZEPAM — FDA approvallorazepam ER

    Sponsor: RISING. Form: TABLET. Route: ORAL

    full page →lorazepam ER →fda approvals ↗
    ›Jan 5, 2026approval
    ← prev
    page 1 of 24
    next →
    236d ago
    AMOXICILLIN AND CLAVULANATE POTASSIUM (AMOXICILLIN) — FDA approvalamoxicillin

    Sponsor: SANDOZ INC. Form: FOR SUSPENSION. Route: ORAL

    full page →amoxicillin →fda approvals ↗
    ›Jan 5, 2026approval236d agoSUCRALFATE — FDA approvalSUCRALFATE

    Sponsor: GLENMARK PHARMS LTD. Form: SUSPENSION. Route: ORAL

    full page →SUCRALFATE →fda approvals ↗
    ›Jan 5, 2026approval236d agoHALOPERIDOL DECANOATE — FDA approvalZydus Therapeutics Inc

    Sponsor: ZYDUS PHARMS. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Jan 5, 2026approval236d agoOXYMORPHONE HYDROCHLORIDE — FDA approvalOXYMORPHONE HYDROCHLORIDE

    Sponsor: ACTAVIS ELIZABETH. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →OXYMORPHONE HYDROCHLORIDE →fda approvals ↗
    ›Jan 5, 2026approval236d agoCARBAMAZEPINE — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: AMNEAL PHARMS. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 6, 2026approval235d agoOLOPATADINE HYDROCHLORIDE — FDA approvalPataday

    Sponsor: GLAND. Form: SOLUTION/DROPS. Route: OPHTHALMIC

    full page →Pataday →fda approvals ↗
    ›Jan 6, 2026approval235d agoCIPROFLOXACIN AND DEXAMETHASONE (CIPROFLOXACIN) — FDA approvalBedford Laboratories

    Sponsor: UPSHER SMITH LABS. Form: SUSPENSION/DROPS. Route: OTIC

    full page →fda approvals ↗
    ›Jan 6, 2026approval235d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

    Sponsor: HIKMA. Form: SOLUTION. Route: ORAL

    full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗
    ›Jan 6, 2026approval235d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

    Sponsor: HIKMA. Form: SOLUTION. Route: ORAL

    full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗
    ›Jan 6, 2026approval235d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

    Sponsor: HIKMA. Form: SOLUTION. Route: ORAL

    full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗
    ›Jan 6, 2026approval235d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

    Sponsor: HIKMA. Form: SOLUTION. Route: ORAL

    full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗
    ›Jan 6, 2026approval235d agoOLANZAPINE — FDA approvalolanzapine ODT

    Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL

    full page →olanzapine ODT →fda approvals ↗
    ›Jan 6, 2026approval235d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

    Sponsor: VISTAPHARM LLC. Form: SOLUTION. Route: ORAL

    full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗
    ›Jan 6, 2026approval235d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

    Sponsor: VISTAPHARM LLC. Form: SOLUTION. Route: ORAL

    full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗
    ›Jan 6, 2026approval235d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

    Sponsor: VISTAPHARM LLC. Form: SOLUTION. Route: ORAL

    full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗
    ›Jan 6, 2026approval235d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

    Sponsor: VISTAPHARM LLC. Form: SOLUTION. Route: ORAL

    full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗
    ›Jan 6, 2026approval235d agoOXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalIGC Pharma, Inc.

    Sponsor: SANALUZ. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 6, 2026approval235d agoOLANZAPINE — FDA approvalolanzapine ODT

    Sponsor: STRIDES PHARMA INTL. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL

    full page →olanzapine ODT →fda approvals ↗
    ›Jan 6, 2026approval235d agoMECLIZINE HYDROCHLORIDE — FDA approvalMECLIZINE HYDROCHLORIDE

    Sponsor: RISING. Form: TABLET. Route: ORAL

    full page →MECLIZINE HYDROCHLORIDE →fda approvals ↗
    ›Jan 6, 2026approval235d agoOXYCODONE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: NOVEL LABS INC. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Jan 6, 2026approval235d agoOXYCODONE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: NOVEL LABS INC. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Jan 6, 2026approval235d agoOXYCODONE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: NOVEL LABS INC. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Jan 6, 2026approval235d agoOXYCODONE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: NOVEL LABS INC. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Jan 6, 2026approval235d agoAMONDYS 45 (CASIMERSEN) — FDA approvalcasimersen

    Sponsor: SAREPTA THERAPS INC. Form: SOLUTION. Route: INTRAVENOUS

    full page →casimersen →fda approvals ↗
    $VNDA5.3300+1.91%
    $AMRX17.54-2.61%
    $PRGO14.48+2.84%
    $VTRS16.94+0.53%
    $IGC0.2670+0.41%
    $IGC0.2670+0.41%
    $IGC0.2670+0.41%
    $IGC0.2670+0.41%
    $AMRX17.54-2.61%
    $IGC0.2670+0.41%
    $AMRX17.54-2.61%
    $AMRX17.54-2.61%
    $AMRX17.54-2.61%
    $SRPT19.14-1.62%
    $AMRX17.54-2.61%